Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05004662 · ClinicalTrials.gov registry record · NA
Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers
A NA study of Smoking Cessation, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Active
- Registry status
- NA
- Development phase
- 520
- Enrollment target
- 1
- Study location
NCT05004662: Active NA study of Smoking Cessation, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT05004662 is a NA study of Smoking Cessation that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 520 participants, above the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target (10% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05004662, a NA study of Smoking Cessation, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 520 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the efficacy and economic impact of a theoretically-based, fully automated, interactive smartphone-based smoking cessation intervention.
Primary Outcome
Participants who report no smoking, not even a puff, within the past 7 days
Conditions Studied
Interventions
- DRUG Nicotine patch
- DRUG Nicotine lozenge
- BEHAVIORAL Smartphone-delivered automated treatment
- BEHAVIORAL Counceling
Study Locations (1)
Florida
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 520 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2026-06-03 |
| Phase | NA |
What the registry record for NCT05004662 still lists
NCT05004662 is an interventional study that assigns participants to a tested intervention. The registered 520 participants enrollment target is mid-sized for trials with a published cap, above the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target (10% higher).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Nicotine patch is the first listed.
NCT05004662 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05004662 about?
NCT05004662 is a clinical study titled "Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers". This study will evaluate the efficacy and economic impact of a theoretically-based, fully automated, interactive smartphone-based smoking cessation intervention.
What is the current status of trial NCT05004662?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 520 participants. The study started on 2021-12-01. Estimated completion is 2026-06-03.
What conditions does trial NCT05004662 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT05004662?
The interventions under investigation include: Nicotine patch (DRUG), Nicotine lozenge (DRUG), Smartphone-delivered automated treatment (BEHAVIORAL), Counceling (BEHAVIORAL).
Who is sponsoring clinical trial NCT05004662?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05004662 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05004662's enrollment target sits among peer trials
520 50th of 188 higher than 139 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
- NCT04656496 · 520 participants · NA
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
- NCT05445778 · 520 participants · Phase 3
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- NCT05498428 · 520 participants · Phase 2
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI